← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
TransUnion: Revenue grew 9.4% to $4.576B from $4.184B. Net income grew 60.1% to $455.4M from $284.4M. Free cash flow grew 28.0% to $661.6M from $516.7M. Operating margin expanded 280 bps to 18.74%. TransUnion's annual comparison also shows stock compensation grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 9.4%OK
- Profitability — Net income grew 60.1% to $455.4M from $284.4MOK
- Cash flow — Free cash flow grew 28.0% to $661.6M from $516.7MOK
- Margins — Operating margin expanded 280 bps to 18.74%OK
- Accounting — No overriding statistical warningNote
- Insiders — 0 purchases and 26 salesWatch
Business
TransUnion provides consumer-credit information, identity, fraud, marketing and analytics solutions using large data assets.
Where the revenue comes from
Fiscal 2025, as TransUnion reports it. History and quarterly detail are in the app.
- U.S. Markets$3.6B
- International$1.0B
Leadership changes
From TransUnion's own filings, the day they're filed.
- Sayan Chakraborty · directors · appointmenteff. 2026-01-05
- Charlotte B. Yarkoni · directors · appointmenteff. 2026-01-05
- Timothy J. Martin · President · departureeff. 2025-01-01
Latest filings
- 8-K · Company announcement2026-07-28
- 10-Q · Quarterly report2026-07-28
- 8-K · Company announcement2026-05-15
- 8-K · Company announcement2026-04-28
- 10-Q · Quarterly report2026-04-28
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about TransUnion, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.